Incyte | INCY - 利息收入

金融业

USD

USD 7.34B

现金及等价物

USD 4.02B

USD 104.5M

USD 5.48B

USD 1.49B

USD 39.43M

USD 344.17M

USD 367.97M

2.62K

EPS每股收益

USD 1.81

股本和储备

USD 5.62B

USD 1.17B

债务利息支出

USD 569K

USD 33.69M

USD 29.41M

USD 26.24B

USD 303.33M

USD 5.62B

USD 324.17M

普通股股本

USD 199.95M

15.35

USD 343.6M

USD 1.27B

销售和管理费用

USD 328.1M

USD 115.62M

贸易债权人

USD 228.62M

应收帐款人

USD 1.05B

	利息收入	更改		日
Acadia Pharmaceuticals	USD 8.33M		86K	2025-12
Agios Pharmaceuticals	USD 12.41M		959K	2025-12
Alnylam Pharmaceuticals	USD 26.63M		2.05M	2025-12
BioCryst Pharmaceuticals	USD -0.13		3.59M	2024-12
Biogen	USD 37.9M		700K	2026-03
BioMarin Pharmaceutical	USD 22.56M		3.35M	2026-03
Eli Lilly	USD 65M		25M	2025-09
Exelixis	USD 16.13M		1.3M	2026-03
Gilead Sciences	USD 95M		7M	2025-12
Incyte	USD 33.69M		2.93M	2026-03
Ionis Pharmaceuticals	USD -0.66		0.29	2024-12
MacroGenics	USD 1.55M		26K	2026-03
Merck	USD 69M		27M	2025-12
Moderna	USD 70M		3M	2025-12
Nektar Therapeutics	USD -0.18		0.07	2024-09
Pfizer	USD 115M		51M	2026-03
Puma Biotechnology	USD 0.41		0.5	2024-09
Regeneron Pharmaceuticals	USD 193.3M		18.2M	2025-12
Sarepta Therapeutics	USD 8.74M		359K	2025-12
Ultragenyx Pharmaceutical	USD 6.51M		649K	2025-12
Vertex Pharmaceuticals	USD 114.8M		7.1M	2026-03